Interactive Discussions
Discover a wide range of topics that provide the know-how needed to deal with a broad range of benign hematologic disorders
Led by Industry's Top Experts
Exchange ideas with colleauges and prominent experts in respective specialty areas
7.5 hours of Continuing Education
Participants can earn up to 7.5 AMA PRA Category 1 Credits™
A continuing medical educational program provided by
Don’t miss this one-day CME meeting providing the knowledge and know-how needed to deal with a broad range of benign hematologic disorders
After attending this conference, healthcare professionals will be able to:
- Summarize advances in the pathophysiology and workup of non-neoplastic blood disorders
- Recognize new insights into diagnostic approaches for non-neoplastic blood disorders
- Identify and integrate updates in the treatment and management of non-neoplastic blood disorders
- Recognize the utility of novel anticoagulants
- Assess recent breakthroughs in transfusion medicine and in addressing iron overload in hematologic disorders
Event Pricing
Fellows, Residents, Pharmacists, Nurses, Technicians
Prior to October 7, 2019- Earn a maximum of 7.5 AMA PRA Category 1 Credits™
- Gain the knowledge and know-how to deal with a broad range of benign hematologic disorders, from immune thrombocytopenia (ITP) and venous thromboembolism to iron overload, and much more
- Discounted Pricing exclusively via QxMD – use code QXMDNNH to get an extra 5% off
Physicians
Prior to October 7, 2019- Earn a maximum of 7.5 AMA PRA Category 1 Credits™
- Gain the knowledge and know-how to deal with a broad range of benign hematologic disorders, from immune thrombocytopenia (ITP) and venous thromboembolism to iron overload, and much more
- Discounted Pricing exclusively via QxMD – use code QXMDNNH to get an extra 5% off
Industry
Prior to October 7, 2019- Earn a maximum of 7.5 AMA PRA Category 1 Credits™
- Gain the knowledge and know-how to deal with a broad range of benign hematologic disorders, from immune thrombocytopenia (ITP) and venous thromboembolism to iron overload, and much more
- Discounted Pricing exclusively via QxMD – use code QXMDNNH to get an extra 5% off
Fellows, Residents, Pharmacists, Nurses, Technicians
Onsite- Earn a maximum of 7.5 AMA PRA Category 1 Credits™
- Gain the knowledge and know-how to deal with a broad range of benign hematologic disorders, from immune thrombocytopenia (ITP) and venous thromboembolism to iron overload, and much more
- Discounted Pricing exclusively via QxMD – use code QXMDNNH to get an extra 5% off
Physicians
Onsite- Earn a maximum of 7.5 AMA PRA Category 1 Credits™
- Gain the knowledge and know-how to deal with a broad range of benign hematologic disorders, from immune thrombocytopenia (ITP) and venous thromboembolism to iron overload, and much more
- Discounted Pricing exclusively via QxMD – use code QXMDNNH to get an extra 5% off
Industry
Onsite- Earn a maximum of 7.5 AMA PRA Category 1 Credits™
- Gain the knowledge and know-how to deal with a broad range of benign hematologic disorders, from immune thrombocytopenia (ITP) and venous thromboembolism to iron overload, and much more
- Discounted Pricing exclusively via QxMD – use code QXMDNNH to get an extra 5% off
Sign Up Today with our Discounted Pricing
Co-Chairs
Howard Liebman, MD
Professor of Hematology
Dr. Liebman is on the foreront of research in thrombotic and hemorrhagic disorders. His lab is currently studying the genetic risk factors responsible for thrombotic diseases including venous thrombosis, pulmonary embolis, arterial thrombosis and thrombosis associated with cancer chemotherapy.
Since 1999, Dr. Liebman is the author of co-author of over 100 medical articles and chapters and has led well over a hundred lectures across the United States, South America, Europe and Japan on a variety of medical topics. He has also been the recipeint of millions of dollars in research grants, reviewed a number of medical journals and is a former Chair of the Massachusetts Governor’s Task Force subcommittee on experimental therapies and clinical trials for AIDS.
Vinod Pullarkat, MD
Clinical Professor of Hematology & Hematopoietic Cell Transplantation
Dr. Pullarkat first came to City of Hope in 2002 as a fellow and clinical instructor in bone marrow transplantation. He then joined the faculty full time in 2003 as an assistant professor and subsequent associate professor in the Department of Hematology & Hematopoietic Cell Transplantation, until departing City of Hope in 2010.
Dr. Pullarkat’s clinical research interests center on acute leukemias, autoimmune hematologic disease and bone marrow transplantation. He has more than 50 peer reviewed publications, and multiple reviews, abstracts and book chapters to his credit, and has filed for two patents.
Frequently Asked Questions
Where is the course located?
Le Meridien Delfina
530 Pico Boulevard
Santa Monica, CA 90405
310-399-9344
Which sessions are included in the course?
October 19, 2019
| 7:00 AM | 8:00 AM | Breakfast |
| 8:00 AM | 8:15 AM | Introduction – Goals of Meeting Vinod Pullarkat, MD |
| 8:15 AM | 8:45 AM | Approach to Peripheral Blood Cytopenia Vinod Pullarkat, MD |
| 8:45 AM | 9:00 AM | Discussion |
| 9:00 AM | 9:30 AM | Diagnosis and Current Management of Immune Thrombocytopenia (ITP) James B. Bussel, MD |
| 9:30 AM | 9:45 AM | Discussion |
| 9:45 AM | 10:15 AM | Advances in Management of Autoimmune Hemolytic Anemia Howard Liebman, MD |
| 10:15 AM | 10:30 AM | Discussion |
| 10:30 AM | 10:45 AM | Break |
| 11:05 AM | 11:15 AM | Q&A |
| 11:15 AM | 12:15 PM | Updates on USPSTF Recommendations: A Year-in-Review Quyen Ngo-Metzger, MD, MPH |
| 10:45 AM | 11:15 AM | Thrombotic Thrombocytopenic Purpura (TTP) and Atypical Hemolytic Uremic Syndrome (aHUS) Ilene Weitz, MD |
| 11:15 AM | 11:30 AM | Discussion |
| 11:30 AM | 12:00 PM | Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria (PNH) Ryotaro Nakamura, MD |
| 12:00 PM | 12:15 PM | Discussion |
| 12:15 PM | 12:30 PM | Lunch |
| 12:30 PM | 1:15 PM | Independent Symposium (CME/CE is not provided for this session) |
| 1:15 PM | 1:30 PM | Dessert Break |
| 1:30 PM | 2:00 PM | Management of Iron Overload in Hematologic Disorders Vinod Pullarkat, MD |
| 2:00 PM | 2:15 PM | Discussion |
| 2:15 PM | 2:45 PM | Advances in Management of Sickle Cell Anemia Thomas Coates, MD |
| 2:45 PM | 3:00 PM | Discussion |
| 3:00 PM | 3:15 PM | Break |
| 3:15 PM | 3:45 PM | Workup and Management of Venous Thromboembolism Casey O’Connell, MD |
| 3:45 PM | 4:00 PM | Discussion |
| 4:00 PM | 4:30 PM | Direct Acting Oral Anticoagulants for Venous Thromboembolism David Garcia, MD |
| 4:30 PM | 4:45 PM | Discussion |
| 4:45 PM | 5:00 PM | Roundtable Discussion/Q&A All Faculty |